Remodeling of hepatic vascular changes after specific chemotherapy of schistosomal periportal fibrosis

Memorias do Instituto Oswaldo Cruz

Volumn 101, Issue SUPPL. 1, 2006, Pages 267-272

  Andrade, Zilton A ^a   Baptista, Ana Paula ^a   Santana, Thaynã Souto ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Fibrosis reversion; Hepatic schistosomiasis; Vascular changes

Indexed keywords

ANIMALIA; CLEMATIS LASIANTHA; HEPATICA;

EID: 33846429232     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762006000900041     Document Type: Conference Paper

References (20)

1. Andrade ZA 1987. Pathogenesis of pipe-stem fibrosis of the liver (experimental observation on murine schistosomiasis). Mem Inst Oswaldo Cruz 82: 325-334.
2. Andrade ZA, Cheever AW 1993. Characterization of the murine model of schistosomal hepatic periportal fibrosis ("pipestem" fibrosis). Internat J Exper Pathol 74: 195-202.
3. Andrade ZA, Peixoto E, Guerret S, Grimaud JÁ 1992. Hepatic connective tissue changes in hepatosplenic schistosomiasis. Hum Pathol 23: 566-573.
4. Andrade ZA, Sadigursky M 1985. Um estudo comparativo das cepas Feira de Santana (Bahia) e Porto Rico do Schistosoma mansoni na infecção experimental do camundongo. Mem Inst Oswaldo Cruz 80: 37-40.
5. Arthur MJP 2002. Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C (Editorial). Gastroenterology 122: 1525-1528.
6. Bataller R, Brenner DA 2005. Liver fibrosis. J Clin Invest 115: 209-218.
7. Bina JC, Prata A 1983. Regressão da hepatoesplenomegalia pelo tratamento específico da esquistossomose. Rev Soc Bras Med Trop 16: 213-218.
8. Desmet VJ, Roskams T 2004. Cirrhosis reversal: a duel between dogma and myth. J Hepatol 40: 860-867.
9. Dietze RS, Prata A 1986. Rate of reversion of hepatosplenic schistosomiasis after specific chemotherapy. Rev Soc Bras Med Trop 19: 69-73.
10. Geerts A 2001. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Sem Liver Dis 21: 311-335.
11. Homeida MA, Ahmed S, Dafalla A, Sulliman S, Eltom I, Nash T, Bennett JL 1988. Morbidity associated with Schistosoma mansoni infection as determined by ultrasound: a study in Gezira, Sudan. Am J Trop Med Hyg 39: 196-201.
12. Katz N, Brener Z 1966. Evolução clínica de 112 casos de esquistossomose mansoni observados após dez anos de permanência em focos endêmicos de Minas Gerais. Rev Inst Med Trop São Paulo 8: 139-142.
13. Lai WK, Adams DH 2005. Angiogenesis and chronic inflammation; the potencial for novel therapeutic approaches in chronic liver diseases (Editorial). J Hepatol 42: 7-11.
14. Massarrat S, Fallahazad V, Kamalian N 2004. Clinical, biochemical and imaging-verified regression of hepatitis B-induced cirrhosis. Liver Intern 24: 105-109.
15. Mohamed-Ali Q, Doehring-Schwerdtfeger E, Abdel-Rahim IM, Schlake J, Kardoff R, Franke D, Kaiser C, Elsheikh M, Abdalla S, Schafer P, Ehrich JHH 1991. Ultrasonographic investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity seven months after treatment with praziquantel. Am J Trop Med Hyg 44: 444-451.
16. Popper H 1977. Pathologic aspects of cirrhosis. A Review. Am J Pathol 87: 227-264.
17. Rosmorduc O, Wendum D, Corpechot C, Galy B, Sebbag N, Raleigh J, Housset C, Poupon R 1999. Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis. Am J Pathol 155: 1065-1073.
18. Souza MM 2003. Estudos sobre a Fibrose Septal Hepática Induzida por Capillaria Hepatica (Patogênese e Evolução), PhD Thesis, Curso de Pós Graduação em Patologia Experimental, UFBA, Salvador.
19. Theise ND 2003. Liver stem cells: the fall and rise of tissue biology (Editorial). Hepatology 38: 804-806.
20. Warren KS 1966. The pathogenesis of "clay-pipe stem cirrhosis" in mice with chronic schistosomiasis mansoni, with a note on the longevity of the schistosomes. Am J Pathol 49: 477-489.